RD
Vivos Inc.
RDGL · OTC
$0.05 -4.76% (-$0.00)
1M -8.55%
Market Cap $24.3M
P/E Ratio -
Div. Yield -
ROE 154.92%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 8.82x
P/S 245.20x
EV/EBITDA N/A
Growth
83 /100
Growing Book val. growth 0.00%
Rev. growth 23.28%
FCF growth N/A
Profitability
0 /100
Weak Net margin 3,633.27%
Op. margin 2,852.46%
FCF margin 2,513.73%
Quality
0 /100
Poor ROE 154.92%
ROA 125.04%
Asset turnover 0.03x
Debt
100 /100
Low Current ratio 48.85x
Debt/Equity 0.04x
Net debt/EBITDA N/A
Stability
43 /100
Moderate Rev. volatility 95.46%
EPS volatility 11.59%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RDGL
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael K. Korenko
Employees
1
Headquarters
Kennewick